Course coordinator: Dr Wee Hwee-Lin

Associate Professor, Saw Swee Hock School of Public Health and Department of Pharmacy, Faculty of Science, National University of Singapore

Dr Wee is a joint Associate Professor in the Saw Swee Hock School of Public Health and Department of Pharmacy, Faculty of Science at the National University of Singapore. Her current work involves understanding patient preferences for high cost treatments, public preferences for preemptive pharmacogenetic testing and factors associated with well-being among Singaporeans.

Lecturer: Dr Charles Zheng Qishi

Epidemiologist, Singapore Clinical Research Institute

Dr Zheng joined Singapore Clinical Research Institute in 2014 as an Epidemiologist. His interests lie in systematic review and meta-analysis for intervention, diagnostic and observational studies, design and statistical analysis for observational study and health economic evaluation. He is currently collaborating with investigators in clinical research on cardiovascular diseases, orthopaedics and paediatrics. In addition, as a member of the Cochrane Singapore, he teaches in Cochrane systematic review workshops and provides lectures related with evidence-based medicine.

Lecturer: Dr David Bin-Chia Wu

Regional Director, Real World Evidence & Health Economics (Asia Pacific)
The Janssen Pharmaceutical Companies of Johnson & Johnson

Dr David Wu Bin-Chia is the Regional Director of Real World Evidence & Health Economics at The Janssen Pharmaceutical Companies of Johnson & Johnson in Singapore and is also an Adjunct Senior Lecturer of Monash University Malaysia. His diverse research activities centred around generating evidence through economic evaluations based on various economic modelling and biostatistical approaches to inform healthcare policy decision-making. He has collaborated extensively with international institutions including the World Health Organization, the United States Agency for International Development, Centers for Disease Control in Taiwan, the Malaysian Ministry of Health, Ministry of Health (the Philippines), and has provided expert advice and technical support to many pharmaceutical companies in health economics and outcomes research.

Lecturer: Dr Luo Nan 

Associate Professor, Saw Swee Hock School of Public Health, National University of Singapore

Dr Luo Nan is an Associate Professor in Saw Swee Hock School of Public Health (SSHSPH) at the National University of Singapore (NUS). His main research interest is measurement of patient-reported outcomes (PRO) including health-related quality of life (HRQoL) and health-state utility for use in economic evaluations. Dr Luo is internationally known for his research work on the EQ-5D instruments. His teaching areas are health services research methods and questionnaire design.

Lecturer: Mr Adrien Gras

Head of Market Access & HEOR, APAC, Ipsos

Mr Adrien Gras is highly experienced leader in global pharmaceutical and medical device market access and HEOR. Adrien currently leads a team of experts in the field across the APAC region. He has been involved in all aspects of product development, from R&D activities such as drug target identification and drug discovery, pipeline commercial strategy, economic modelling, government reimbursement negotiation, and lifecycle management. He has published peer-reviewed journals and manuals in the fields of biochemistry, health economics and policy. Adrien was awarded a BSc in Biotechnology from Imperial College before completing an MRes in Structural Biology at Birkbeck College.

Lecturer: Mr Omar Akhtar

HEOR Director APAC, Ipsos

Mr Omar Akhtar is currently Director of Health Economics and Outcomes for APAC with Ipsos. His research interests focus on healthcare system strengthening, HTA development in APAC, health economics, evidence synthesis, and epidemiology. He has collaborated extensively with government and academics in ASEAN, East Asia, and the Middle East. More generally, he has undertaken projects and published in every continent save for Antarctica, including submitting multiple NICE submissions and publishing bilingual Japanese literature reviews. Formerly, he was a health economist with CADTH (the Canadian HTA agency), bringing insights from both sides of the proverbial table in evaluating and funding health technologies.

Lecturer: Mr David Champion 

Senior Director at Ansea Healthcare Consulting

Mr David Champion has 17 years’ experience in the healthcare industry having held a variety of country, regional & global roles in Pricing, Market Access & Health Economics in multiple geographies including Australia, Thailand, Singapore, Hong Kong & UK, in companies such as Pfizer, Novartis, Amgen. He has worked directly with and prepared numerous reimbursement submissions to payors & HTA bodies including Australian PBAC, and MSAC, UK NICE, Thailand HiTAP, and Singapore’s ACE. David has led the preparation of more than 10 Global Value Dossiers and designed, implemented and executed over a dozen patient access programs in Hong Kong, Singapore, Thailand, Vietnam, Philippines and Malaysia in collaboration with 3rd party patient organizations and various governments including Singapore, Philippines, Thailand and Vietnam.

Lecturer: Dr. Hwang Yi-Fu Jeff

Lecturer, Saw Swee Hock School of Public Health, National University of Singapore

Dr Jeff Hwang is an Occupational Physician and his primary appointment is at the Woodlands Health Campus. He was previously a lecturer at the Saw Swee Hock School of Public Health (SSHSPH) at the National University of Singapore (NUS). His main research area is in workplace safety and health services, and his teaching areas are in occupational medicine, total workplace safety and health, and clinical epidemiology.